Jingwei Bai
白净卫
Jingwei Bai (白净卫) is a gene-sequencing technologist and co-founder of Qitan Technology (齐碳科技), where he serves as co-founder and chief scientist . His background spans academic and industry research in nanoscale single-molecule sequencing: he holds a PhD from UCLA and completed postdoctoral work at IBM's Watson Laboratory, with his expertise sitting at the intersection of protein engineering, biochips, electronic circuitry, and AI . At Qitan, Bai has been the scientific lead behind the company's push to develop China's first fully self-developed nanopore gene sequencer, the QNome-3841, which was announced in late 2021 and positioned for mass production . Elsewhere's corpus does not cover Bai's activities beyond 2022.
AI-generated — may contain errors, please verify.
Coverage
Multiple Innovative Companies Gain Global Recognition, Breakthroughs Achieved in Computational Biology, LiDAR, and Other Fields | Rongbao · July
Major events in July.
When Will We Achieve "Genomic Sequencing Freedom"? | Gaorong Ventures "Future"
A Conversation with the Creator of China's First Mass-Produced Nanopore Gene Sequencer
Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.
Leading nanopore gene sequencing company **Qitan Technology** has raised over RMB 100 million in funding, led by Gaorong Ventures.
Focused on the independent R&D of nanopore gene sequencers, dedicated to making gene sequencing technology accessible to every household.
